0 Σχόλια
0 Μοιράστηκε
259 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Global Biopharma Buffer Market to More Than Double from USD 1.1 Billion in 2023 to USD 2.16 Billion by 2032Global Biopharma Buffer Market to More Than Double from USD 1.1 Billion in 2023 to USD 2.16 Billion by 2032 The global Biopharma Buffer Market critical for the manufacture, storage, and transport of biologics and other biopharmaceuticals is set to witness compelling growth over the next decade. As per the latest analysis by, the market was valued at USD 1.1 billion in 2023, and is projected to...0 Σχόλια 0 Μοιράστηκε 730 Views 0 Προεπισκόπηση
-
Single Use System in Biopharma Manufacturing Market Growth Report | Trends & Insights 2022-27MarkNtel Advisors recently published a detailed industry analysis of the Global Single Use System in Biopharma Manufacturing Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market. Global Single Use System in Biopharma Manufacturing Market, Share, and Trends Analysis Report – Industry Overview and...0 Σχόλια 0 Μοιράστηκε 916 Views 0 Προεπισκόπηση
-
Snelkoppelingen naar Alpha Biopharma die maar weinigen kennenKoop anabole steroïden online om de spiergroei en krachttoename te maximaliseren tijdens bulk- of cutcycli. Deze legale middelen bieden een uitstekende prijs-kwaliteitverhouding. De aanschaf van anabole steroïden kan bepaalde risico's met zich meebrengen. Omdat de regelgeving per rechtsgebied verschilt, kunnen onbedoelde overtredingen leiden tot hoge boetes of gevangenisstraf....0 Σχόλια 0 Μοιράστηκε 490 Views 0 Προεπισκόπηση
-
Nucleic Acid Therapeutics CDMO Market to Reach $4.9B by 2031: Inside the 11.09% CAGR SurgeMarket Overview The global nucleic acid therapeutics CDMO market size was valued at USD 1,908.41 million in 2022. It is estimated to reach USD 4,917.52 million by 2031, growing at a CAGR of 11.09% during the forecast period (2023–2031). The global Nucleic Acid Therapeutics CDMO market continues to evolve rapidly, driven by shifting consumer trends, rising...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση